中国耳鼻咽喉头颈外科
中國耳鼻嚥喉頭頸外科
중국이비인후두경외과
Chinese Archives of Otolaryngology-Head and Neck Surgery
2015年
9期
459-462
,共4页
听觉丧失,突发性%糖皮质激素类%中耳
聽覺喪失,突髮性%糖皮質激素類%中耳
은각상실,돌발성%당피질격소류%중이
Hearing Loss,Sudden%Glucocorticoids%Ear,Middle
目的观察糖皮质激素全身应用和鼓室内注射联合治疗重度和极重度突发性聋的临床疗效,以探索糖皮质激素治疗突发性聋的方法。方法对54例重度和极重度突发性聋患者的临床资料进行回顾性分析,所有患者均给予口服激素、改善微循环、溶栓抗凝等治疗,同意加用鼓室内注射激素的患者为治疗组,其余患者为对照组,治疗2周后复查纯音测听。结果治疗组和对照组患者平均听阈改善均具有显著统计学意义,但两组之间疗效无差异(P=0.194)。治疗组与对照组中重度突发性聋患者间疗效无差异(P=0.251),两组中极重度突发性聋患者间疗效也无差异(P=0.380)。结论糖皮质激素全身应用联合鼓室内注射治疗重度和极重度突发性聋有效,但并不能得到较单独全身用药更好的疗效。
目的觀察糖皮質激素全身應用和鼓室內註射聯閤治療重度和極重度突髮性聾的臨床療效,以探索糖皮質激素治療突髮性聾的方法。方法對54例重度和極重度突髮性聾患者的臨床資料進行迴顧性分析,所有患者均給予口服激素、改善微循環、溶栓抗凝等治療,同意加用鼓室內註射激素的患者為治療組,其餘患者為對照組,治療2週後複查純音測聽。結果治療組和對照組患者平均聽閾改善均具有顯著統計學意義,但兩組之間療效無差異(P=0.194)。治療組與對照組中重度突髮性聾患者間療效無差異(P=0.251),兩組中極重度突髮性聾患者間療效也無差異(P=0.380)。結論糖皮質激素全身應用聯閤鼓室內註射治療重度和極重度突髮性聾有效,但併不能得到較單獨全身用藥更好的療效。
목적관찰당피질격소전신응용화고실내주사연합치료중도화겁중도돌발성롱적림상료효,이탐색당피질격소치료돌발성롱적방법。방법대54례중도화겁중도돌발성롱환자적림상자료진행회고성분석,소유환자균급여구복격소、개선미순배、용전항응등치료,동의가용고실내주사격소적환자위치료조,기여환자위대조조,치료2주후복사순음측은。결과치료조화대조조환자평균은역개선균구유현저통계학의의,단량조지간료효무차이(P=0.194)。치료조여대조조중중도돌발성롱환자간료효무차이(P=0.251),량조중겁중도돌발성롱환자간료효야무차이(P=0.380)。결론당피질격소전신응용연합고실내주사치료중도화겁중도돌발성롱유효,단병불능득도교단독전신용약경호적료효。
[ABSTRACT]OBJECTIVETo evaluate the efficacy of combined oral and intratympanic glucocorticoids treatment for severe to profound sudden sensorineural hearing loss(SSNHL).METHODSFifty-four patients with severe to profound SSNHL were retrospectively studied. They were treated with oral steroids, vasodilators, anticoagulants. The patients who accepted intratympanic methylprednisolone sodium succinate were included the therapy group, the others were included in the control group. Hearing improvements were analyzed respectively after two weeks.RESULTSHearing in both groups were improved significantly after treatment(P<0.01), but there was no difference in hearing improvements between two groups(P=0.194). The efficacy for severe SSNHL patients in therapy group was equal to those who were in control group (P=0.251), so was the efficacy for profound SSNHL patients in both groups(P=0.380).CONCLUSIONThe combined systemic and intratympanic glucocorticoids treatment was effective for patients with severe to profound SSNHL, but while with no better efficacy than oral glucocorticoid alone.